Article

Improving Maternal Mental Health After a Child's Diagnosis of Autism Spectrum Disorder Results From a Randomized Clinical Trial

Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts2Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts.
JAMA pediatrics 11/2013; 168(1). DOI: 10.1001/jamapediatrics.2013.3445
Source: PubMed

ABSTRACT IMPORTANCE The prevalence of psychological distress among mothers of children with autism spectrum disorder (ASD) suggests a need for interventions that address parental mental health during the critical period after the child's autism diagnosis when parents are learning to navigate the complex system of autism services. OBJECTIVE To investigate whether a brief cognitive behavioral intervention, problem-solving education (PSE), decreases parenting stress and maternal depressive symptoms during the period immediately following a child's diagnosis of ASD. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial compared 6 sessions of PSE with usual care. Settings included an autism clinic and 6 community-based early intervention programs that primarily serve low-income families. Participants were mothers of 122 young children (mean age, 34 months) who recently received a diagnosis of ASD. Among mothers assessed for eligibility, 17.0% declined participation. We report outcomes after 3 months of follow-up (immediate postdiagnosis period). INTERVENTIONS Problem-solving education is a brief, cognitive intervention delivered in six 30-minute individualized sessions by existing staff (early intervention programs) or research staff without formal mental health training (autism clinic). MAIN OUTCOMES AND MEASURES Primary outcomes were parental stress and maternal depressive symptoms. RESULTS Fifty-nine mothers were randomized to receive PSE and 63 to receive usual care. The follow-up rate was 91.0%. Most intervention mothers (78.0%) received the full PSE course. At the 3-month follow-up assessment, PSE mothers were significantly less likely than those serving as controls to have clinically significant parental stress (3.8% vs 29.3%; adjusted relative risk [aRR], 0.17; 95% CI, 0.04 to 0.65). For depressive symptoms, the risk reduction in clinically significant symptoms did not reach statistical significance (5.7% vs 22.4%; aRR, 0.33; 95% CI, 0.10 to 1.08); however, the reduction in mean depressive symptoms was statistically significant (Quick Inventory of Depressive Symptomatology score, 4.6 with PSE vs 6.9 with usual care; adjusted mean difference, -1.67; 95% CI, -3.17 to -0.18). CONCLUSIONS AND RELEVANCE The positive effects of PSE in reducing parenting stress and depressive symptoms during the critical postdiagnosis period, when parents are asked to navigate a complex service delivery system, suggest that it may have a place in clinical practice. Further work will monitor these families for a total of 9 months to determine the trajectory of outcomes. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01021384.

Download full-text

Full-text

Available from: William Beardslee, Dec 04, 2014
1 Follower
 · 
114 Views
  • Source
    • "The adequacy of the psychometric properties of the QIDS-SR 16 has been demonstrated across multiple and diverse samples, primarily in the USA: outpatients with MDD (Carmody et al., 2006; Liu et al., 2013; Rush et al., 2003; Trivedi et al., 2004; Zimmerman et al., 2012) or bipolar disorder (Bernstein et al., 2010a; Trivedi et al., 2004); primary-care medical patients (Lamoureux et al., 2010); patients with chronic kidney disease (Hedayati et al., 2009) or with co-morbid asthma and MDD (Brown et al., 2008); adolescents (Bernstein et al., 2010b), young adults (González et al., 2013), and elderly individuals (Doraiswamy et al., 2010). Although the Spanish version of the QIDS-SR 16 is increasingly used (e.g., Bernstein et al., 2007; Feinberg et al., 2014; Lesser et al., 2008; Rush et al., 2006b; Trinh et al., 2011), to date, there is a striking lack of studies addressing its psychometric properties. By contrast, these have been recently examined for the parent IDS- SR 30 in a large Spanish sample of MDD patients (Gili et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Psychometrically robust and easy-to-administer scales for depressive symptoms are necessary for research and clinical assessment. This is a psychometric study of the Spanish version of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16) in a clinical sample. Method One-hundred and seventy-three patients (65% women) with a psychiatric disorder including depressive symptoms were recruited. Such symptoms were assessed by means of the QIDS-SR16 and two interviewer-rated instruments: the 17-item Hamilton Depression Rating Scale (HDRS17) and the Clinical Global Impression-Severity (CGI-S) scale. Self-rated measures of health-related quality of life, subjective happiness and perceived social support were also obtained. Dimensionality, internal consistency, construct validity, criterion validity, and responsiveness to change of the QIDS-SR16 were examined. Results Exploratory and confirmatory factor analyses replicated the original one-factor structure. The Spanish version of the QIDS-SR16 showed good to excellent internal consistency (α=0.88), convergent validity [HDRS17 (r=0.77), CGI-S (r=0.78)], and divergent validity [EuroQol-5D Visual Analogue Scale (r=−0.78), Subjective Happiness Scale (r=−0.72)]. The QIDS-SR16 was excellent in discriminating clinically significant from non-significant depressive symptomatology (area under ROC curve=0.93). It also showed a high sensitivity to treatment-related changes: patients with greater clinical improvement showed a greater decrease in QIDS-SR16 scores (p<0.001). Limitations The study was conducted in a single center, which may limit the generalizability of the findings. Conclusions The Spanish version of the QIDS-SR16 retains the soundness of metric characteristics of the original version which makes the scale an invaluable instrument to assess depressive symptoms.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Psychometrically robust and easy-to-administer scales for depressive symptoms are necessary for research and clinical assessment. This is a psychometric study of the Spanish version of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16) in a clinical sample. Method: One hundred and seventy-three patients (65% women) with a psychiatric disorder including depressive symptoms were recruited. Such symptoms were assessed by means of the QIDS-SR16 and two interviewer rated instruments: the 17 item Hamilton Depression Rating Scale (HDRS17) and the Clinical Global Impression Severity (CG1-5) scale. Self rated measures of health related quality of life, subjective happiness and perceived social support were also obtained. Dimensionality, internal consistency, construct validity, criterion validity, and responsiveness to change of the QIDS-SR16 were examined. Results: Exploratory and confirmatory factor analyses replicated the original one-factor structure. The Spanish version of the QIDS-SR16 showed good to excellent internal consistency (alpha=0.88), convergent validity IHDRS17 (r=0.77), CGI-S Cr=0.78)], and divergent validity IEuroQo1-5D Visual Analogue Scale (r= -0.78), Subjective Happiness Scale (r= 0.72)]. The QIDS-SR16 was excellent in discriminating clinically significant from non-significant depressive symptomatology (area under ROC curve=0.93). It also showed a high sensitivity to treatment-related changes: patients with greater clinical improvement showed a greater decrease in QIDS-SR16 scores (p < 0.001). Lin-drat:ions: The study was conducted in a single center, which may limit the generalizability of the findings. Conclusions: The Spanish version of the QIDS-SR16 retains the soundness of metric characteristics of the original version which makes the scale an invaluable instrument to assess depressive symptoms.
    Journal of Affective Disorders 08/2014; 169C:189-196. DOI:10.1016/j.jad.2014.08.011 · 3.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Depression is a serious disorder with severe and far-reaching consequences. Two decades of observational research have shown robust associations between maternal depression and adverse consequences on offspring (S. Campbell et al., 2004; S. Campbell, P. Matestic, C. von Stauffenberg, R. Mohan, & T. Kirchner, 2007; S. Campbell, A. Morgan-Lopez, M. Cox, & V. McLoyd, 2009; National Research Council and Institute of Medicine, 2009). Depressive symptoms may pose particular risk to infants and toddlers with neurodevelopmental disabilities, whose long-term outcomes depend heavily on the provision of early intervention (EI). EI is most effective with active parental engagement. Maternal depressive symptoms may reduce parental engagement, thereby limiting EI benefits to the child (B. N. Gaynes et al., 2005; O'Hara & Swain, 1996). At present, maternal mental health is not directly addressed in EI. The purpose of this article is to discuss the literature and significance of maternal depression and apply that evidence to mothers of children with developmental delays and disabilities. We conclude that maternal mental health and well-being are currently insufficiently addressed in the EI population. An increased integration of mental health and EI services is needed to serve the unique needs of families who face an increased risk of stress and depression, while coping with their child's special needs.
    Infants and young children 01/2015; 28(1):72-87. DOI:10.1097/IYC.0000000000000024 · 0.91 Impact Factor
Show more